Granahan Investment Management - NABRIVA THERAPEUTICS PLC ownership

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$750,000
-19.6%
1,407,893
+1.8%
0.02%
-26.5%
Q2 2020$933,000
+526.2%
1,383,192
+434.2%
0.03%
+325.0%
Q1 2020$149,000
-57.7%
258,916
-2.8%
0.01%
-50.0%
Q4 2019$352,000
-25.4%
266,384
+12.9%
0.02%
-38.5%
Q3 2019$472,000
-16.2%
235,875
+1.8%
0.03%
-7.1%
Q2 2019$563,000
-0.4%
231,754
+0.2%
0.03%
-6.7%
Q1 2019$565,000
+59.6%
231,373
-4.6%
0.03%
+20.0%
Q4 2018$354,000
-47.0%
242,582
-1.9%
0.02%
-30.6%
Q3 2018$668,000247,2760.04%
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
FIRST NATIONAL CORP /MA/ /ADV 1,000$941,0000.61%
Aisling Capital Management LP 1,910,287$1,098,0000.48%
Values First Advisors, Inc. 410,653$236,1250.28%
FRAZIER MANAGEMENT LLC 4,256,526$2,448,0000.28%
Vivo Capital, LLC 1,704,130$980,0000.09%
SABBY MANAGEMENT, LLC 367,613$211,0000.09%
Orbimed Advisors 4,644,600$2,671,0000.04%
Rock Springs Capital Management LP 1,050,000$604,0000.02%
Clear Creek Financial Management, LLC 112,000$62,0000.02%
EXANE DERIVATIVES 82,078$47,193,0000.01%
View complete list of NABRIVA THERAPEUTICS PLC shareholders